Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease
The PEACE Trial
Torbjørn Omland, MD, PhD, MPH*,
,2,*,
Marc S. Sabatine, MD, MPH
,
,3,
Kathleen A. Jablonski, PhD||,1,4,
Madeline Murguia Rice, PhD||,1,4,
Judith Hsia, MD||,5,
Ragnhild Wergeland, MT#,
Sverre Landaas, MD, PhD**,
Jean L. Rouleau, MD, FACC
,
,
Michael J. Domanski, MD, FACC
,
Christian Hall, MD, PhD*,
,6,
Marc A. Pfeffer, MD, PhD, FACC
,
,
Eugene Braunwald, MD, FACC
,
for the PEACE Investigators
* Department of Medicine, Akershus University Hospital, Lorenskog, Norway
Faculty of Medicine, University of Oslo, Oslo, Norway
Cardiovascular Division, Brigham and Womens Hospital, Boston, Massachusetts
Department of Medicine, Harvard Medical School, Boston, Massachusetts
|| George Washington University, Rockville, Maryland, and Washington, DC
# Department of Medical Biochemistry, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway
** Department of Clinical Chemistry, Ullevaal University Hospital, Oslo, Norway

Montreal Heart Institute, Montreal, Quebec, Canada

Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

National Heart, Lung, and Blood Institute, Bethesda, Maryland.

View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 NT-ProBNP and Cardiovascular Death
Kaplan-Meier curves showing the cumulative incidence of death due to a cardiovascular cause in patients according to quartiles of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations.
|
|

View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 NT-ProBNP and Heart Failure
Kaplan-Meier curves showing the cumulative incidence of fatal or nonfatal congestive heart failure (CHF) in patients according to quartiles of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations.
|
|

View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 NT-ProBNP and Stroke
Kaplan-Meier curves showing the cumulative incidence of fatal or nonfatal stroke in patients according to quartiles of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations.
|
|
Copyright © 2007 by the American College of Cardiology Foundation.